Odyssey Health, Inc. financial data

Symbol
ODYY on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
2300 West Sahara Avenue, Suite 800 #4012, Las Vegas, NV
State of incorporation
NV
Fiscal year end
July 31
Former names
Odyssey Group International, Inc. (to 2/18/2022)
Latest financial report
10-K - Q2 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 4.34 % -46.6%
Debt-to-equity -118 % +29.1%
Return On Equity -67.4 % -165%
Return On Assets -11.7 % +98.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 96.7M shares +18.3%
Common Stock, Shares, Outstanding 96.7M shares +22.3%
Entity Public Float 6.88M USD -37.5%
Common Stock, Value, Issued 96.7K USD +22.3%
Weighted Average Number of Shares Outstanding, Basic 97.1M shares +17.4%
Weighted Average Number of Shares Outstanding, Diluted 97.1M shares +17.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 25.8K USD
General and Administrative Expense 1.51M USD -29%
Operating Income (Loss) 14.3M USD
Net Income (Loss) Attributable to Parent -842K USD +85.8%
Earnings Per Share, Basic -0.01 USD/shares +85.7%
Earnings Per Share, Diluted -0.01 USD/shares +85.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 66K USD +5250%
Assets, Current 56.9K USD -86%
Property, Plant and Equipment, Net 0 USD -100%
Assets 586K USD +28.6%
Accounts Payable, Current 1.28M USD -29%
Accrued Liabilities, Current 13.8K USD 0%
Liabilities, Current 5.92M USD -10.5%
Liabilities 4.7M USD +95.7%
Retained Earnings (Accumulated Deficit) -61M USD -1.51%
Stockholders' Equity Attributable to Parent -5.33M USD +13.4%
Liabilities and Equity 586K USD +28.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -59.9K USD +79%
Net Cash Provided by (Used in) Financing Activities 221K USD -18.4%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 96.7M shares +22.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.38K USD -93.5%
Deferred Tax Assets, Valuation Allowance 2.86M USD -3.31%
Deferred Tax Assets, Gross 2.86M USD -3.31%
Payments to Acquire Property, Plant, and Equipment 8.04K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 55.6M USD +3.18%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.54K USD -55%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 594K USD -6.16%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%